Dealing with a messy patchwork of state laws, cannabis companies are getting creative with their marketing strategies. Through OOH advertising, companies are creating brand awareness, marketing their products and driving traffic to their websites and storefronts.
As the Northeast continues to legalize adult use cannabis incrementally, it is looking like Rhode Island will follow closely behind Connecticut on the path to legalize adult use cannabis. Shortly behind Rhode Island comes growing support for legalization in Pennsylvania and Delaware too.
Complex regulatory standards, dosage limits, price disparities and a limited variety of products all hinder the Canadian edibles market and prevent the category from flourishing as it should.
Update: Governor Ned Lamont has signed S.B. 1201 into law, officially legalizing cannabis in the state of Connecticut and making it the 19th state in the country to end cannabis prohibition.
The California-based company has developed an ISO-accredited hemp testing panel that tests for a variety of contaminants, designed to cover requirements set by every state in the country.
How effective is your internal assessment program to proactively identifying and mitigating business risks? In this piece, Vaillencourt addresses common questions that cannabis businesses ask when developing an audit program and provides some tips for staying on top of self-assessments to avoid costly compliance fines.
In a blog post published yesterday, Amazon’s Senior Vice President, Dave Clark, announced the company’s support for the MORE Act and their updated drug testing policy.
HUB International, an insurance brokerage serving the cannabis industry, has announced Bradley Rutt as their new U.S. cannabis specialty leader, working alongside Jay Virdi, chief sales officer for cannabis.
Technology in cannabis packaging is advancing. Blockchain-supported tracking, QR codes and authenticity markers can help companies keep track of supply chain logistics and prevent counterfeiting simultaneously.
Sherman Hom is a research scientist and microbiology expert at New Jersey’s Division of Public Health and Environmental Laboratories. He now joins the Medicinal Genomics team as their new director of regulatory affairs.